Canada markets open in 4 hours 10 minutes

Helix BioPharma Corp. (HBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.24000.0000 (0.00%)
At close: 03:58PM EDT
Full screen
Previous Close0.2400
Open0.2300
Bid0.2000 x 0
Ask0.2300 x 0
Day's Range0.2300 - 0.2400
52 Week Range0.1700 - 0.9500
Volume359
Avg. Volume25,612
Market Cap41.843M
Beta (5Y Monthly)-0.04
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Jerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.

    VANCOUVER, BC / ACCESSWIRE / April 22, 2022 / Mr. Jerzy Wilczewski announces the acquisition of 7,700,000 common shares ("Common Shares") in the capital of Helix Biopharma Corp.

  • ACCESSWIRE

    Helix Biopharma Corp. Closes Private Placement

    RICHMOND HILL, ON / ACCESSWIRE / April 21, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47, today announces that it has closed a private placement financing for net proceeds of $2,002,000 from the issuance of 7,700,000 common shares at a price of $0.

  • ACCESSWIRE

    Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members

    RICHMOND HILL, ON / ACCESSWIRE / April 18, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platformDOS47, is pleased to announce that Artur Gabor has been appointed as the Company's Chief Executive Officer with immediate effect.